{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T09:02:27Z","timestamp":1784192547412,"version":"3.55.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:00:00Z","timestamp":1755648000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:00:00Z","timestamp":1755648000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hum Hypertens"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Metabolic and bariatric surgery (MBS) is an effective treatment for obesity and metabolic syndrome. Evidence regarding the impact of MBS on hypertension outcomes is limited by short-term follow-up. Thus, this retrospective cohort study was designed to compare blood pressure (BP) control, number of antihypertensive medications (AHMs), development of apparent treatment resistant hypertension (ATRH), and remission of hypertension between patients treated with and without MBS. Adults with BMI\u2009\u2265\u200935\u2009kg\/m<jats:sup>2<\/jats:sup> and a new diagnosis of hypertension receiving care within the Veterans Health Administration system from 2000\u20132019 were included. Generalized estimating equations and time-updated Cox models with inverse probability of treatment weighting to address time-updated confounding were used. Over a median follow-up of 5.1 years, 183702 patients with BMI\u2009\u2265\u200935\u2009kg\/m<jats:sup>2<\/jats:sup> and hypertension were managed medically and 3965 were managed surgically. At baseline, those who underwent MBS were more likely to be women than men (22 vs. 10%). Patients treated surgically demonstrated significantly better BP control over time, with an average 5.4\u2009mm Hg (95% CI 4.9\u20135.9) lower systolic BP and 1.8\u2009mm Hg (95% CI 1.5\u20132.1) lower diastolic BP. Compared to patients treated medically, those who received MBS had 32% higher likelihood of complete AHM discontinuation (95% CI 1.23\u20131.42). Patients treated with MBS were 14% less likely to develop ATRH (95% CI 0.78\u20130.95). Overall, among patients with obesity and hypertension, treatment with MBS was associated with durably improved BP control compared to medical management, including lower systolic and diastolic BPs, higher AHM cessation, and lower rates of ATRH.<\/jats:p>","DOI":"10.1038\/s41371-025-01063-z","type":"journal-article","created":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T14:21:29Z","timestamp":1755699689000},"page":"683-689","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The Effect of Bariatric Surgery on Hypertension Outcomes: A Retrospective Cohort Study"],"prefix":"10.1038","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6599-0397","authenticated-orcid":false,"given":"Jesse E.","family":"Passman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Bader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadim","family":"Mahmud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristoffel R.","family":"Dumon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Wachtel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feibi","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4649-079X","authenticated-orcid":false,"given":"Jordana B.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,20]]},"reference":[{"key":"1063_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijchy.2020.100044","volume":"6","author":"MD Chobufo","year":"2020","unstructured":"Chobufo MD, Gayam V, Soluny J, Rahman EU, Enoru S, Foryoung JB, et al. Prevalence and control rates of hypertension in the USA: 2017\u20132018. International Journal of Cardiology Hypertension. 2020;6:100044.","journal-title":"International Journal of Cardiology Hypertension"},{"key":"1063_CR2","doi-asserted-by":"publisher","first-page":"e23","DOI":"10.1161\/HYPERTENSIONAHA.120.15153","volume":"76","author":"L Rethy","year":"2020","unstructured":"Rethy L, Shah NS, Paparello JJ, Lloyd-Jones DM, Khan SS. Trends in hypertension-related cardiovascular mortality in the United States, 2000 to 2018. Hypertension. 2020;76:e23\u2013e25.","journal-title":"Hypertension"},{"key":"1063_CR3","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1001\/jamacardio.2016.1326","volume":"1","author":"S Sidney","year":"2016","unstructured":"Sidney S, Quesenberry CP, Jaffe MG, Sorel M, Nguyen-Huynh MN, Kushi LH, et al. Recent trends in cardiovascular mortality in the United States and public health goals. JAMA cardiology. 2016;1:594\u20139.","journal-title":"JAMA cardiology"},{"key":"1063_CR4","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.metabol.2018.09.005","volume":"92","author":"YC Chooi","year":"2019","unstructured":"Chooi YC, Ding C, Magkos F. The epidemiology of obesity. Metabolism. 2019;92:6\u201310.","journal-title":"Metabolism"},{"key":"1063_CR5","doi-asserted-by":"publisher","first-page":"2440","DOI":"10.1056\/NEJMsa1909301","volume":"381","author":"ZJ Ward","year":"2019","unstructured":"Ward ZJ, Bleich SN, Cradock AL, Barrett JL, Giles CM, Flax C, et al. Projected US state-level prevalence of adult obesity and severe obesity. New England Journal of Medicine. 2019;381:2440\u201350.","journal-title":"New England Journal of Medicine"},{"key":"1063_CR6","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1161\/CIRCRESAHA.116.305697","volume":"116","author":"JE Hall","year":"2015","unstructured":"Hall JE, do Carmo JM, da Silva AA, Wang Z, Hall ME. Obesity-induced hypertension: interaction of neurohumoral and renal mechanisms. Circulation research. 2015;116:991\u20131006.","journal-title":"Circulation research"},{"key":"1063_CR7","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1097\/HJH.0000000000000046","volume":"32","author":"M Olszanecka-Glinianowicz","year":"2014","unstructured":"Olszanecka-Glinianowicz M, Zygmuntowicz M, Owczarek A, Elibol A, Chudek J. The impact of overweight and obesity on health-related quality of life and blood pressure control in hypertensive patients. Journal of hypertension. 2014;32:397\u2013407.","journal-title":"Journal of hypertension"},{"key":"1063_CR8","doi-asserted-by":"publisher","first-page":"80","DOI":"10.21037\/gs.2019.12.03","volume":"9","author":"OA Shariq","year":"2020","unstructured":"Shariq OA, McKenzie TJ. Obesity-related hypertension: a review of pathophysiology, management, and the role of metabolic surgery. Gland surgery. 2020;9:80.","journal-title":"Gland surgery"},{"key":"1063_CR9","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1136\/heartjnl-2012-301778","volume":"98","author":"AR Vest","year":"2012","unstructured":"Vest AR, Heneghan HM, Agarwal S, Schauer PR, Young JB. Bariatric surgery and cardiovascular outcomes: a systematic review. Heart. 2012;98:1763\u201377.","journal-title":"Heart"},{"key":"1063_CR10","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1177\/1060028014529260","volume":"48","author":"SM Wilhelm","year":"2014","unstructured":"Wilhelm SM, Young J, Kale-Pradhan PB. Effect of bariatric surgery on hypertension: a meta-analysis. Annals of Pharmacotherapy. 2014;48:674\u201382.","journal-title":"Annals of Pharmacotherapy"},{"key":"1063_CR11","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1007\/s11695-022-05893-5","volume":"32","author":"G Tajeu","year":"2022","unstructured":"Tajeu G, Johnson E, Buccilla M, Gadegbeku C, Janick S, Rubin D, et al. Changes in Antihypertensive Medication Following Bariatric Surgery. Obes Surg. 2022;32:1312\u201324.","journal-title":"Obes Surg"},{"key":"1063_CR12","doi-asserted-by":"crossref","unstructured":"Passman J, Wall-Wieler E, Liu Y, Zheng F, Cohen JB. Antihypertensive Medication Use Trajectories After Bariatric Surgery: A Matched Cohort Study. Hypertension 2024.","DOI":"10.1161\/HYPERTENSIONAHA.124.23054"},{"key":"1063_CR13","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1161\/CIRCULATIONAHA.117.032130","volume":"137","author":"CA Schiavon","year":"2018","unstructured":"Schiavon CA, Bersch-Ferreira AC, Santucci EV, Oliveira JD, Torreglosa CR, Bueno PT, et al. Effects of bariatric surgery in obese patients with hypertension: the GATEWAY randomized trial (gastric bypass to treat obese patients with steady hypertension). Circulation. 2018;137:1132\u201342.","journal-title":"Circulation"},{"key":"1063_CR14","doi-asserted-by":"publisher","first-page":"685","DOI":"10.7326\/M19-3781","volume":"173","author":"CA Schiavon","year":"2020","unstructured":"Schiavon CA, Bhatt DL, Ikeoka D, Santucci EV, Santos RN, Damiani LP, et al. Three-year outcomes of bariatric surgery in patients with obesity and hypertension: a randomized clinical trial. Annals of internal medicine. 2020;173:685\u201393.","journal-title":"Annals of internal medicine"},{"key":"1063_CR15","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.jacc.2023.11.032","volume":"83","author":"CA Schiavon","year":"2024","unstructured":"Schiavon CA, Cavalcanti AB, Oliveira JD, Machado RH, Santucci EV, Santos RN, et al. Randomized trial of effect of bariatric surgery on blood pressure after 5 years. Journal of the American College of Cardiology. 2024;83:637\u201348.","journal-title":"Journal of the American College of Cardiology"},{"key":"1063_CR16","doi-asserted-by":"publisher","first-page":"289","DOI":"10.7326\/M20-4873","volume":"174","author":"JB Cohen","year":"2021","unstructured":"Cohen JB, Cohen DL, Herman DS, Leppert JT, Byrd JB, Bhalla V. Testing for Primary Aldosteronism and Mineralocorticoid Receptor Antagonist Use Among U.S. Veterans : A Retrospective Cohort Study. Annals of internal medicine. 2021;174:289\u201397.","journal-title":"Annals of internal medicine"},{"key":"1063_CR17","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/S0895-4356(03)00246-4","volume":"57","author":"M Wilchesky","year":"2004","unstructured":"Wilchesky M, Tamblyn RM, Huang A. Validation of diagnostic codes within medical services claims. J Clin Epidemiol. 2004;57:131\u201341.","journal-title":"J Clin Epidemiol"},{"key":"1063_CR18","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1097\/01.mlr.0000207482.02503.55","volume":"44","author":"MF Bullano","year":"2006","unstructured":"Bullano MF, Kamat S, Willey VJ, Barlas S, Watson DJ, Brenneman SK. Agreement between administrative claims and the medical record in identifying patients with a diagnosis of hypertension. Med Care. 2006;44:486\u201390.","journal-title":"Med Care"},{"key":"1063_CR19","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1111\/j.1475-6773.2007.00822.x","volume":"43","author":"H Quan","year":"2008","unstructured":"Quan H, Li B, Saunders LD, Parsons GA, Nilsson CI, Alibhai A, et al. Assessing validity of ICD-9-CM and ICD-10 administrative data in recording clinical conditions in a unique dually coded database. Health Serv Res. 2008;43:1424\u201341.","journal-title":"Health Serv Res"},{"key":"1063_CR20","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1016\/S0140-6736(19)32317-7","volume":"394","author":"MA Suchard","year":"2019","unstructured":"Suchard MA, Schuemie MJ, Krumholz HM, You SC, Chen R, Pratt N, et al. Comprehensive comparative effectiveness and safety of first-line antihypertensive drug classes: a systematic, multinational, large-scale analysis. Lancet. 2019;394:1816\u201326.","journal-title":"Lancet"},{"key":"1063_CR21","doi-asserted-by":"crossref","unstructured":"Muntner P, Shimbo D, Carey RM, Charleston JB, Gaillard T, Misra S et al. Measurement of blood pressure in humans: A scientific statement from the American Heart Association. Hypertension 2019.","DOI":"10.1161\/HYP.0000000000000087"},{"key":"1063_CR22","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","volume":"385","author":"LA Inker","year":"2021","unstructured":"Inker LA, Eneanya ND, Coresh J, Tighiouart H, Wang D, Sang Y, et al. New Creatinine- and Cystatin C-Based Equations to Estimate GFR without Race. The New England journal of medicine. 2021;385:1737\u201349.","journal-title":"The New England journal of medicine"},{"key":"1063_CR23","doi-asserted-by":"publisher","first-page":"e53","DOI":"10.1161\/HYP.0000000000000084","volume":"72","author":"RM Carey","year":"2018","unstructured":"Carey RM, Calhoun DA, Bakris GL, Brook RD, Daugherty SL, Dennison-Himmelfarb CR, et al. Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association. Hypertension. 2018;72:e53\u2013e90.","journal-title":"Hypertension"},{"key":"1063_CR24","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1093\/aje\/kwn164","volume":"168","author":"SR Cole","year":"2008","unstructured":"Cole SR, Hernan MA. Constructing inverse probability weights for marginal structural models. American journal of epidemiology. 2008;168:656\u201364.","journal-title":"American journal of epidemiology"},{"key":"1063_CR25","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1161\/HYPERTENSIONAHA.119.14359","volume":"75","author":"G Jaffe","year":"2020","unstructured":"Jaffe G, Gray Z, Krishnan G, Stedman M, Zheng Y, Han J, et al. Screening Rates for Primary Aldosteronism in Resistant Hypertension: A Cohort Study. Hypertension. 2020;75:650\u20139.","journal-title":"Hypertension"},{"key":"1063_CR26","doi-asserted-by":"publisher","first-page":"e38","DOI":"10.1161\/HYP.0000000000000202","volume":"78","author":"ME Hall","year":"2021","unstructured":"Hall ME, Cohen JB, Ard JD, Egan BM, Hall JE, Lavie CJ, et al. Weight-Loss Strategies for Prevention and Treatment of Hypertension: A Scientific Statement From the American Heart Association. Hypertension. 2021;78:e38\u2013e50.","journal-title":"Hypertension"},{"key":"1063_CR27","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1001\/jamasurg.2016.2317","volume":"151","author":"ML Maciejewski","year":"2016","unstructured":"Maciejewski ML, Arterburn DE, Van Scoyoc L, Smith VA, Yancy WS, Weidenbacher HJ, et al. Bariatric surgery and long-term durability of weight loss. JAMA surgery. 2016;151:1046\u201355.","journal-title":"JAMA surgery"},{"key":"1063_CR28","doi-asserted-by":"publisher","first-page":"e1001925","DOI":"10.1371\/journal.pmed.1001925","volume":"12","author":"IJ Douglas","year":"2015","unstructured":"Douglas IJ, Bhaskaran K, Batterham RL, Smeeth L. Bariatric surgery in the United Kingdom: a cohort study of weight loss and clinical outcomes in routine clinical care. PLoS medicine. 2015;12:e1001925.","journal-title":"PLoS medicine"},{"key":"1063_CR29","first-page":"1313","volume":"91","author":"KR Dumon","year":"2011","unstructured":"Dumon KR, Murayama KM. Bariatric surgery outcomes. Surgical Clinics. 2011;91:1313\u201338.","journal-title":"Surgical Clinics"},{"key":"1063_CR30","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1056\/NEJMoa1614362","volume":"377","author":"Collaborators GO","year":"2017","unstructured":"Collaborators GO. Health effects of overweight and obesity in 195 countries over 25 years. New England journal of medicine. 2017;377:13\u201327.","journal-title":"New England journal of medicine"},{"key":"1063_CR31","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/oby.20181","volume":"21","author":"L Landsberg","year":"2013","unstructured":"Landsberg L, Aronne LJ, Beilin LJ, Burke V, Igel LI, Lloyd\u2010Jones D, et al. Obesity\u2010related hypertension: Pathogenesis, cardiovascular risk, and treatment\u2014A position paper of the The Obesity Society and the American Society of Hypertension. Obesity. 2013;21:8\u201324.","journal-title":"Obesity"},{"key":"1063_CR32","doi-asserted-by":"crossref","unstructured":"Hall ME, do Carmo JM, da Silva AA, Juncos LA, Wang Z, Hall JE. Obesity, hypertension, and chronic kidney disease. International journal of nephrology and renovascular disease 2014: 75-88.","DOI":"10.2147\/IJNRD.S39739"},{"key":"1063_CR33","doi-asserted-by":"publisher","first-page":"3279","DOI":"10.1007\/s11695-021-05415-9","volume":"31","author":"P Noparatayaporn","year":"2021","unstructured":"Noparatayaporn P, Thavorncharoensap M, Chaikledkaew U, Bagepally BS, Thakkinstian A. Incremental net monetary benefit of bariatric surgery: systematic review and meta-analysis of cost-effectiveness evidences. Obesity surgery. 2021;31:3279\u201390.","journal-title":"Obesity surgery"},{"key":"1063_CR34","doi-asserted-by":"publisher","first-page":"2933","DOI":"10.1007\/s11695-017-2719-1","volume":"27","author":"S Kizy","year":"2017","unstructured":"Kizy S, Jahansouz C, Downey MC, Hevelone N, Ikramuddin S, Leslie D. National trends in bariatric surgery 2012\u20132015: demographics, procedure selection, readmissions, and cost. Obesity surgery. 2017;27:2933\u20139.","journal-title":"Obesity surgery"}],"container-title":["Journal of Human Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41371-025-01063-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41371-025-01063-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41371-025-01063-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T22:05:02Z","timestamp":1759788302000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41371-025-01063-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,20]]},"references-count":34,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["1063"],"URL":"https:\/\/doi.org\/10.1038\/s41371-025-01063-z","relation":{},"ISSN":["1476-5527"],"issn-type":[{"value":"1476-5527","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,20]]},"assertion":[{"value":"21 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"FZ is employed by Intuitive. HW receives salary support from the National Cancer Institute of the National Institutes of Health, #K08 CA270385. JEP, AB, NM, KD, and JBC have nothing to disclose.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the IRB of the Corporal Michael J. Crescenz Veterans Affairs Medical Center in Philadelphia, PA. All methods were performed in accordance with relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"ETHICAL APPROVAL"}}]}}